Furthermore, in addition to affecting transcription, epigenetic disorders exacerbate genetic instability in gliomas by altering chromatin structure: mutations in histones and ATRX lead to genetic instability due to abnormal deposition of histone marks, while mutant IDH epigenetically enhances DNA damage response signaling. The gene discussed is IDH1; the disease is central nervous system cancer.